Understanding COVID-19 Vaccine Hesitancy in Nigeria Through University Community Lens
Abstract
It is widely acknowledged that vaccination represents one of the greatest advances in public health in human history. Nonetheless, vaccine rejection or hesitancy is a public health issue that has continuously thwarted coordinated attempts by health officials to stop the spread of infectious diseases like the Coronavirus in Nigeria. It is critical to assess public perception, which will encourage vaccine acceptance through focused initiatives. Therefore, this study assesses vaccination reluctance among the Benue State University student community. A cross-sectional descriptive design was used in the study. A questionnaire was distributed to 150 participants, selected through the convenience sample technique. SPSS was used to enter and analyse the data. Eighty-seven percent of the respondents were between their first and third years, and the majority (63%) were over 18-30. Only 68% of the respondents thought the virus was real.
Additionally, none of the students had a favourable disposition towards the vaccination. The respondents cited fear of vaccine side effects (46.2%), distrust of the government (33.9%), vaccine efficacy (12.5%), and a variety of mystical possibilities (7.4%) as the major causative factors behind their hesitation to receive the vaccination. Available data show a serious communication breakdown between the respondents and the regional health authority. To improve public acceptance of the COVID-19 vaccine, broad and focused public health promotion initiatives are needed to alleviate some public concerns.
Keywords
Full Text:
PDFReferences
1. CDC. (2021). Basics of COVID-19. Retrieved from https://www.cdc.gov/covid/index.html
2. Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., Wesolowski, A., & Metcalf, C. J. E. (2021). Infectious disease in an era of global change. Nature Reviews Microbiology, 20(4), 193–205. doi: 10.1038/s41579-021-00639-z
3. Hanna, P., Issa, A., Noujeim, Z., Hleyhel, M., & Saleh, N. (2022). Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study. Journal of Pharmaceutical Policy and Practice, 15(1). doi: 10.1186/s40545-021-00403-x
4. WHO. (n. d.). Coronavirus disease (COVID-19). Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019
5. Sharpe, H. R., Gilbride, C., Allen, E., Belij‐Rammerstorfer, S., Bissett, C., Ewer, K., & Lambe, T. (2020). The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology, 160(3), 223–232. doi: 10.1111/imm.13222
6. Zimmer, K., Corum, J., Wee, S.-L., & Kristoffersen, M. (2022, August 31). Coronavirus Vaccine Tracker. Retrieved from https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
7. Kerr, J. R., Schneider, C. R., Recchia, G., Dryhurst, S., Sahlin, U., Dufouil, C., Arwidson, P., Freeman, A. L. J., & van der Linden, S. (2020). Predictors of COVID-19 vaccine acceptance across time and countries. doi: 10.1101/2020.12.09.20246439
8. Wang, K., Wong, E. L. Y., Ho, K. F., Cheung, A. W. L., Chan, E. Y. Y., Yeoh, E. K., & Wong, S. Y. S. (2020). Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey. Vaccine, 38(45), 7049–7056. doi: 10.1016/j.vaccine.2020.09.021
9. Alfageeh, E. I., Alshareef, N., Angawi, K., Alhazmi, F., & Chirwa, G. C. (2021). Acceptability of a COVID-19 Vaccine among the Saudi Population. Vaccines, 9(3), 226. doi: 10.3390/vaccines9030226
10. Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines, 9(2), 160. doi: 10.3390/vaccines9020160
11. Sharun, K., Tiwari, R., Iqbal Yatoo, Mohd., Patel, S. K., Natesan, S., Dhama, J., Malik, Y. S., Harapan, H., Singh, R. K., & Dhama, K. (2020). Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects. Expert Opinion on Biological Therapy, 20(9), 1033–1046. doi: 10.1080/14712598.2020.1796963
12. OECD. (2021, May 10). Enhancing public trust in COVID‑19 vaccination: The role of governments. Retrieved from https://www.oecd.org/en/publications/enhancing-public-trust-in-covid-19-vaccination-the-role-of-governments_eae0ec5a-en.html
13. Acheampong, T., Akorsikumah, E. A., Osae-Kwapong, J., Khalid, M., Appiah, A., & Amuasi, J. H. (2021). Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana. Vaccines, 9(8), 814. doi: 10.3390/vaccines9080814
14. Olomofe, C. O., Soyemi, K. V., Udomah, B. F., Owolabi, A. O., Ajumuka, E. E., Igbokwe, M. C., … & Ariyo, O. E. (2021). Predictors of Uptake of a Potential Covid-19 Vaccine Among Nigerian Adults. Journal of Vaccines & Vaccination, 12(1), 1–8.
15. Baiye, B., Oguntola, I. (2021, April 18). Will you take the COVID-19 Vaccine? A Household Survey on the Perception of Nigerians towards a COVID-19 vaccine. Retrieved from https://articles.nigeriahealthwatch.com/will-you-take-the-covid-19-vaccine-a-household-survey-on-the-perception-of-nigerians-towards-a-covid-19-vaccine/
16. Ekowo, O. E., Manafa, C., Isielu, R. C., Okoli, C. M., Chikodi, I., Onwuasoanya, A. F., Echendu, S. T., Ihedoro, I., Nwabueze, U. D., & Nwoke, O. C. (2022). A cross sectional regional study looking at the factors responsible for the low COVID-19 vaccination rate in Nigeria. Pan African Medical Journal, 41. doi: 10.11604/pamj.2022.41.114.30767
17. Tamrat Assefa Tadesse, Ashenafi Antheneh, Ashenafi Teklu, Asres Teshome, Bemnet Alemayehu, Alemu Belayneh, Dessale Abate, & Alfoalem Araba Abiye. (2022). COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study. Ethiopian Journal of Health Sciences, 32(6). doi: 10.4314/ejhs.v32i6.2
18. Forman, R., Shah, S., Jeurissen, P., Jit, M., & Mossialos, E. (2021). COVID-19 vaccine challenges: What have we learned so far and what remains to be done? Health Policy, 125(5), 553–567. doi: 10.1016/j.healthpol.2021.03.013
19. World Health Organisation. (2020). Behavioural considerations for acceptance and uptake of COVID-19 vaccines. Retrieved from https://www.who.int/publications/i/item/9789240016927
20. Nossier, S. A. (2021). Vaccine hesitancy: the greatest threat to COVID-19 vaccination programs. Journal of the Egyptian Public Health Association, 96(1). doi: 10.1186/s42506-021-00081-2
21. Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Razizadeh, M. H., Turner, D. L., & Turner, R. J. (2021). Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. Vaccines, 9(5), 467. doi: 10.3390/vaccines9050467
22. Kumari, A., Ranjan, P., Chopra, S., Kaur, D., Kaur, T., Upadhyay, A. D., Isaac, J. A., Kasiraj, R., Prakash, B., Kumar, P., Dwivedi, S. N., & Vikram, N. K. (2021). Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: A cross-sectional survey from one thousand two hundred and forty-nine participants. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(3), 987–992. doi: 10.1016/j.dsx.2021.04.015
23. Echoru, I., Ajambo, P. D., Keirania, E., & Bukenya, E. E. M. (2021). Socio-demographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda. BMC Public Health, 21(1). doi: 10.1186/s12889-021-11197-7
24. Tulloch, O., Roldan de Jong, T., & Bardosh, K. (2021). Data Synthesis: COVID-19 Vaccine Perceptions in Africa: Social and Behavioural Science Data, March 2020-March 2021. SSHAP. doi: 10.19088/sshap.2028
25. Jamshed, S. (2014). Qualitative research method-interviewing and observation. Journal of Basic and Clinical Pharmacy, 5(4), 87. doi: 10.4103/0976-0105.141942
26. Ritchie, J., Lewis, J., & Elam, G. (2003). Designing and selecting samples. In Qualitative research practice: A guide for social science students and researchers (pp. 77–108). Thousand Oaks.
27. Bowen, G. A. (2008). Naturalistic inquiry and the saturation concept: a research note. Qualitative Research, 8(1), 137–152. doi: 10.1177/1468794107085301
28. Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative analysis. London: Sage Publishers.
29. Malterud, K., Siersma, V. D., & Guassora, A. D. (2016). Sample Size in Qualitative Interview Studies. Qualitative Health Research, 26(13), 1753–1760. doi: 10.1177/1049732315617444
30. Vasileiou, K., Barnett, J., Thorpe, S., & Young, T. (2018). Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Medical Research Methodology, 18(1). doi: 10.1186/s12874-018-0594-7
31. Uzochukwu, I. C., Eleje, G. U., Nwankwo, C. H., Chukwuma, G. O., Uzuke, C. A., Uzochukwu, C. E., Mathias, B. A., Okunna, C. S., Asomugha, L. A., & Esimone, C. O. (2021). COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institution. Therapeutic Advances in Infectious Disease, 8. doi: 10.1177/20499361211054923
32. Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021). Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines, 9(3), 300. doi: 10.3390/vaccines9030300
33. Engelbrecht, M., Heunis, C., & Kigozi, G. (2022). COVID-19 Vaccine Hesitancy in South Africa: Lessons for Future Pandemics. International Journal of Environmental Research and Public Health, 19(11), 6694. doi: 10.3390/ijerph19116694
34. IPSOS. (2020, August 31). Three in four adults globally say they would get a vaccine for COVID‑19. Retrieved from https://www.ipsos.com/en-us/news-polls/WEF-covid-vaccine-global
35. AfricaCDC. (2020, December 17). Majority of Africans would take a safe and effective COVID‑19 vaccine. Retrieved from https://africacdc.org/news-item/majority-of-africans-would-take-a-safe-and-effective-covid-19-vaccine/
36. Tobin, E. A., Okonofua, M., & Azeke, A. (2021). Acceptance of a COVID‑19 vaccine in Nigeria: A population‑based cross‑sectional study. Annals of Medical and Health Sciences Research, 11(5), 1445–1452.
37. Madu, U. A., & Nworie, C. S. (2022). Influence of Ethnocentric Billboard Advertising Messages on Product Consumption in Nigeria: a Study of Hero Lager. Path of Science, 8(5), 7001–7011. doi: 10.22178/pos.81-13
38. Njoga, E. O., Mshelbwala, P. P., Abah, K. O., Awoyomi, O. J., Wangdi, K., Pewan, S. B., Oyeleye, F. A., Galadima, H. B., Alhassan, S. A., Okoli, C. E., Kwaja, E. Z., Onwumere-Idolor, O. S., Atadiose, E. O., Awoyomi, P. O., Ibrahim, M. A., Lawan, K. M., Zailani, S. A., Salihu, M. D., & Rupprecht, C. E. (2022). COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria. Vaccines, 10(4), 626. doi: 10.3390/vaccines10040626
39. Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., Karukivi, M., Lindfelt, M., & Antfolk, J. (2021). Fearing the disease or the vaccine: The case of COVID-19. Personality and Individual Differences, 172, 110590. doi: 10.1016/j.paid.2020.110590
40. Madu, U. A. (2021). Effectiveness of Social Media in Unifying Fragmented Nigerian Societies. Path of Science, 7(12), 3001–3010. doi: 10.22178/pos.77-5
41. Madu, U. A., Samuel, D. U., Eze, T. K., & Ogar, E. E. (2021). Appraisal of Social Media Marketing as Effective Tool in Boosting Entrepreneurship for Economic Development in Nigeria. Journal of Humanities & Social Science, 26(9), 34-47.
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Cajethan Okechukwu Madu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Email the author